Nkarta (NKTX) Income towards Parent Company (2019 - 2026)

Nkarta's (NKTX) quarterly Income towards Parent Company came in at -$34.0 million in Q1 2026, up 9.81% year-on-year from -$31.0 million in Q1 2025, and down 0.85% quarter-over-quarter from -$33.8 million in Q4 2025.

Nkarta (NKTX) Income towards Parent Company (2019 - 2026) Analysis & Trends

Nkarta's Income towards Parent Company history runs 8 years deep, the most recent figure standing at -$34.0 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 9.81% year-over-year to -$34.0 million in Q1 2026; TTM through Mar 2026 was -$190.5 million, a 42.28% decrease from a year earlier, with the FY2025 full-year figure at -$257.9 million, down 99.55% from the prior year.
  • Income towards Parent Company eased to -$34.0 million in Q1 2026 per NKTX's latest filing, from -$33.8 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$26.6 million in Q1 2022 and bottomed at -$180.2 million in Q2 2023.
  • The 5-year median for Income towards Parent Company is -$37.7 million (2025), against an average of -$65.4 million.
  • Across the five-year window, Income towards Parent Company plunged 514.86% in 2022 and surged 82.94% in 2024, its largest moves.
  • Year by year, Income towards Parent Company stood at -$36.1 million in 2022, then decreased by 20.49% to -$43.5 million in 2023, then climbed by 29.15% to -$30.8 million in 2024, then declined by 9.58% to -$33.8 million in 2025, then decreased by 0.85% to -$34.0 million in 2026.
  • Per Business Quant, the three latest NKTX Income towards Parent Company figures stand at -$34.0 million (Q1 2026), -$33.8 million (Q4 2025), and -$60.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Nkarta 168.94 Mn 168.94 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.04 Mn
Dec 31, 2025 -33.75 Mn
Sep 30, 2025 -60.52 Mn
Jun 30, 2025 -62.15 Mn
Mar 31, 2025 -37.74 Mn
Dec 31, 2024 -30.80 Mn
Sep 30, 2024 -34.57 Mn
Jun 30, 2024 -30.75 Mn
Mar 31, 2024 -60.42 Mn
Dec 31, 2023 -43.47 Mn
Sep 30, 2023 -169.42 Mn
Jun 30, 2023 -180.22 Mn
Mar 31, 2023 -36.65 Mn
Dec 31, 2022 -36.08 Mn
Sep 30, 2022 -88.41 Mn
Jun 30, 2022 -145.81 Mn
Mar 31, 2022 -26.59 Mn
Dec 31, 2021 -23.97 Mn
Sep 30, 2021 -39.69 Mn
Jun 30, 2021 -23.71 Mn